RecruitingNCT06917378

TRIO CTO (Taiwan Research Initiative on Coronary Total Occlusion)

The Multicenter Study to Evaluate Clinical and Angiographic Factors in Patients With Coronary Artery Chronic Total Occlusion in Taiwan


Sponsor

National Taiwan University Hospital

Enrollment

5,000 participants

Start Date

Jan 1, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

Coronary chronic total occlusions (CTO) present a significant challenge in the field of interventional cardiology. These complex lesions, characterized by complete blockage of a coronary artery for a prolonged duration, often require specialized techniques and strategies to achieve successful revascularization.


Eligibility

Min Age: 20 YearsMax Age: 120 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Percutaneous coronary intervention of coronary chronic total occlusion for people with chronic total occlusion (cto). The study is currently recruiting participants at 3 locations. People eligible for this study include aged 20 Years to 120 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPercutaneous coronary intervention of coronary chronic total occlusion

Coronary CTO was identified by coronary angiography, and its revascularization was attempted by either antegrade, retrograde or both approach.


Locations(3)

Chang Gung Memorial Hospital

New Taipei City, Taiwan

National Taiwan University Hospital

Taipei, Taiwan

Taipei Veterans General Hospital

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06917378


Related Trials